SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-037095
Filing Date
2021-07-15
Accepted
2021-07-15 17:07:23
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea144245-s3_oramedpharma.htm S-3 391638
2 OPINION OF SULLIVAN & WORCESTER LLP ea144245ex5-1_oramed.htm EX-5.1 22589
3 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea144245ex23-1_oramed.htm EX-23.1 5957
4 GRAPHIC img_001.jpg GRAPHIC 5805
5 GRAPHIC ex5-1_001.jpg GRAPHIC 12080
6 GRAPHIC ex5-1_002.jpg GRAPHIC 3234
7 GRAPHIC ex23-1_001.jpg GRAPHIC 5017
8 GRAPHIC ex23-1_002.jpg GRAPHIC 6718
  Complete submission text file 0001213900-21-037095.txt   467320
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-257926 | Film No.: 211093266
SIC: 2834 Pharmaceutical Preparations